Approximately 24,768 bottles of Clobazam Tablets (10mg) are being recalled due to manufacturing deviations that resulted in levels of residual solvents exceeding safety specifications. These chemicals are typically used in the production process, but their presence at levels above set limits can compromise the quality and safety of the medication. This recall involves 100-count bottles of prescription Clobazam, and consumers should contact their pharmacist or healthcare provider to discuss alternative treatment options.
The presence of residual solvents above safety limits can lead to adverse health effects or unexpected drug interactions depending on the specific solvent and the level of exposure over time.
You have 2 options:
Recall #: D-0348-2024; Quantity: 24,768 bottles
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.